2: Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for Up to Five Oligometastases: Preliminary Results of the SABR-5 Trial. (October 2021) - Olson, Robert; Jiang, Will; Liu, Mitchell; Bergman, Alanah; Schellenberg, Devin; Mou, Benjamin; Alexander, Abraham; Carolan, Hannah; Hsu, Fred; Miller, Stacy; Atrchian, Siavash; Chan, Elisa; et al.